Suppr超能文献

参附注射液对休克的治疗作用

Therapeutic Effects of Shenfu Injection in Shock.

作者信息

Zhang Ming-Qing, Li Chun-Sheng

机构信息

Department of Emergency Medicine, Beijing Jishuitan Hospital, Beijing, 100035, China.

Department of Emergency Medicine, Critical Care Center, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, 100050, China.

出版信息

Chin J Integr Med. 2023 Dec;29(12):1142-1146. doi: 10.1007/s11655-023-3631-2. Epub 2023 May 24.

Abstract

Shock is the clinical manifestation of acute circulatory failure, which results in inadequate utilization of cellular oxygen. It is a common condition with high mortality rates in intensive care units. The intravenous administration of Shenfu Injection (SFI) may attenuate inflammation, regulate hemodynamics and oxygen metabolism; inhibit ischemia-reperfusion responses; and have adaptogenic and antiapoptotic effects. In this review, we have discussed the clinical applications and antishock pharmacological effects of SFI. Further in-depth and large-scale multicenter clinical studies are warranted to determine the therapeutic effects of SFI on shock.

摘要

休克是急性循环衰竭的临床表现,可导致细胞氧利用不足。它是重症监护病房中常见且死亡率高的病症。静脉注射参附注射液(SFI)可能减轻炎症、调节血流动力学和氧代谢;抑制缺血再灌注反应;并具有适应原样作用和抗凋亡作用。在本综述中,我们讨论了SFI的临床应用和抗休克药理作用。有必要进行进一步深入的大规模多中心临床研究,以确定SFI对休克的治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验